DRG International, Inc. is a leading manufacturer of clinical diagnostic and research ELISAs with distributors in over 110 countries. DRG is also the manufacturer of the DRG:HYBRiD-XL®, a fully automated analyzer for Immunoassays and Clinical Chemistry. Founded in 1970, DRG International, Inc. provides a complete range of products and services to the diagnostic and research communities. DRG International’s global headquarters is conveniently situated in Springfield, New Jersey. Only 20 miles from New York City and 80 miles from Philadelphia, PA; DRG International, Inc. is in the heart of the Tri-State Area.
Quality – DRG International, Inc. operates in accordance with the FDA 21 CFR 820 Quality System Regulation as well as the ISO 13485:2016 standard. DRG maintains certifications in both ISO 13485:2016 and MDSAP (Medical Device Single Audit Program) by TÜV Rheinland.
Sales – The majority of DRG sales are in immunodiagnostics worldwide, however, DRG is also an authorized distributor of CHROMagar chromogenic medium within the United States. With our recent MDSAP certification, as well as over 200 FDA approved products and over 75 products registered with Health Canada, we are looking to expand our reach throughout North America and globally. Strong markets for DRG products are throughout Europe, Poland, Russia, the US, the Middle East, Asia- Pacific, China, and South America.
Employees – DRG International employs approximately 120 people worldwide. We have a multi-lingual, multicultural sales and service team ready to serve you.
Founder – Dr. Cyril E. Geacintov (1930-2017)
President & CEO – Mrs. Elke Geacintov
DRG® International, Inc., is committed to providing the medical and research community with cutting edge, easy-to-use and effective diagnostic devices. Founded in 1970, DRG International is constantly looking towards the future in order to continue to produce and distribute the highest-quality products worldwide.
Click a location on the map below to receive more information about the selected office.
|841 Mountain Ave, Springfield Township, NJ 07081, USA|
DRG International, Inc. Global Headquarters
|Frauenbergstraße 18, 35039 Marburg, Germany|
DRG Instruments GmbH, R&D and Production
Tel: +49 (0)-6421/1700-0
RUSSIA - Moscow
|Moscow, Russia, 117218|
DRG Techsystems, ZAO
Tel: +7 (499)-277-07-20
RUSSIA - St. Petersburg
|St Petersburg, Russia, 194156|
DRG Biomed, OOO
Tel: +7 (812)-492-5693/492-5793
|Wita Stwosza 24, 02-661 Warszawa, Poland|
|Šumavská 33, 602 00 Brno-střed, Czechia|
DRG Spol. S.R.O.
News and Updates
DRG is proud to announce the launch of two new Anti-Müllerian Hormone (AMH) assays: AMH ELISA (EIA-6141) AMH DRG HYBRiD XL® (HYE-5770) Clinical Application: AMH has been identified as a reliable marker of ovarian reserve that can help predict early ovarian...
The growth and further development of the North American market is a key priority for us and the sole focus of the new Sales and Business Development Executive we are looking to recruit.
On April 30th, 2020, an organized study by Radboud University Medical Center in Nijmegen, Netherlands, has completed a final report for the DRG International’s first ever Hepcidin Proficiency Test.